| 2026-08-14 | Press release | Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines |
| 2026-08-04 | Presentation | Presentation |
| 2026-08-03 | Press release | Pfizer Quarterly Corporate Performance - Second Quarter 2026 |
| 2026-07-30 | Press release | Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo |
| 2026-07-29 | Press release | European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union |
| 2026-07-22 | Press release | FDA Grants Priority Review for Pfizer’s TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer |
| 2026-07-10 | Press release | Download , U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Ca |
| 2026-07-10 | Press release | U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regard |
| 2026-06-24 | Press release | Download , Pfizer Declares Third-Quarter 2026 Dividend, 06/24/2026, (opens in new window) |
| 2026-06-24 | Press release | FDA Approves Pfizer’s IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance |
| 2026-06-23 | Press release | Download , Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts, 06/23/2026, (o |
| 2026-06-23 | Press release | Event Announcement Open Event Link, PDF file, 08/04/2026, (opens in new window) |
| 2026-06-22 | Press release | Download , Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous |
| 2026-06-22 | Press release | Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small |
| 2026-06-18 | Press release | Download , Pfizer Announces Chief Financial Officer Transition, 06/18/2026, (opens in new window) |
| 2026-06-18 | Press release | Pfizer Announces Chief Financial Officer Transition |
| 2026-06-08 | Press release | Download , U.S. FDA Approves Pfizer’s HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations |
| 2026-06-08 | Press release | U.S. FDA Approves Pfizer’s HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Signi |
| 2026-06-06 | Press release | Download , Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer’s GLP-1 RA Berobenatide |
| 2026-06-06 | Presentation | Presentation(opens in new window) |
| 2026-06-06 | Press release | Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer’s GLP-1 RA Berobenatide |
| 2026-06-01 | Press release | Download , Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference, 06/01/2026, (opens |
| 2026-05-31 | Press release | Download , Pfizer’s BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer, 05 |
| 2026-05-31 | Press release | Pfizer’s BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer |
| 2026-05-30 | Press release | Download , TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate |
| 2026-05-29 | Press release | Download , Seven-Year Analysis from Pfizer’s LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Da |
| 2026-05-28 | Press release | Download , Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative On |
| 2026-05-27 | Press release | Download , Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference, 05/27/2026 |
| 2026-05-20 | Press release | Download , Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results, 05/ |
| 2026-05-13 | Press release | Download , European Commission Approves Pfizer’s HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A |
| 2026-05-05 | Press release | Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts |
| 2026-04-29 | Press release | Download , Pfizer’s ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Rel |
| 2026-04-28 | Press release | Pfizer Reaches Three Settlement Agreements for VYNDAMAX |
| 2026-04-23 | Press release | Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders |
| 2026-04-22 | Press release | Pfizer Declares Second-Quarter 2026 Dividend |
| 2026-04-21 | Press release | Download , Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026, 04/21/2026, (opens in new win |
| 2026-04-20 | Press release | Download , U.S. FDA Grants Priority Review to sBLA for PADCEV + Keytruda as Perioperative Treatment for Muscle-Invasive |
| 2026-04-09 | Press release | Download , Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Sharehol |
| 2026-03-31 | Press release | Press Release(opens in new window) |
| 2026-03-24 | Press release | Download , Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts, 03/24/2026, (open |